Streptomycin/etoposideOtotoxicity and hypothyroidism: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1874卷 / 1期

关键词：

D O I：

10.1007/s40278-021-02903-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：246 / 246

相关论文

共 50 条

[41] OxcarbazepineCentral hypothyroidism: 3 case reports
Reactions Weekly, 2020, 1830 (1) : 261 - 261
[42] AlemtuzumabHyperthyroidism and hypothyroidism: 4 case reports
Reactions Weekly, 2020, 1791 (1) : 22 - 22
[43] SunitinibHyperthyroidism and hypothyroidism: 6 case reports
Reactions Weekly, 2008, 1207 (1) : 32 - 32
[44] NivolumabThyrotoxicosis and hypothyroidism: 3 case reports
Reactions Weekly, 2018, 1724 (1) : 277 - 277
[45] Atezolizumab/nivolumabOvert hypothyroidism and subclinical hypothyroidism: 3 case reports
Reactions Weekly, 2022, 1934 (1) : 89 - 89
[46] Bleomycin/cisplatin/etoposideOtotoxicity: case report
Reactions Weekly, 2021, 1849 (1) : 96 - 96
[47] Cisplatin/etoposideOtotoxicity and fatigue: case report
Reactions Weekly, 2022, 1924 (1) : 159 - 159
[48] AmiodaroneCongenital hypothyroidism in neonates following in utero exposure: 2 case reports
Reactions Weekly, 2009, 1242 (1) : 6 - 6
[49] NivolumabType 1 diabetes mellitus, hypothyroidism and thyrotoxicosis: 2 case reports
Reactions Weekly, 2020, 1795 (1) : 207 - 207
[50] Itraconazole/potassium-iodideSkin rashes and hypothyroidism: 2 case reports
Reactions Weekly, 2023, 1941 (1) : 232 - 232

← 1 2 3 4 5 →